- Home
- CFFN vs RZLT Comparison
CFFN vs RZLT Comparison
Compare CFFN & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFN
- RZLT
- Stock Information
- Founded
- CFFN 1893
- RZLT 2010
- Country
- CFFN United States
- RZLT United States
- Employees
- CFFN N/A
- RZLT N/A
- Industry
- CFFN Savings Institutions
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- CFFN Finance
- RZLT Health Care
- Exchange
- CFFN Nasdaq
- RZLT Nasdaq
- Market Cap
- CFFN 832.5M
- RZLT 713.4M
- IPO Year
- CFFN 1999
- RZLT N/A
- Fundamental
- Price
- CFFN $6.28
- RZLT $9.10
- Analyst Decision
- CFFN Hold
- RZLT Strong Buy
- Analyst Count
- CFFN 1
- RZLT 6
- Target Price
- CFFN $6.50
- RZLT $14.50
- AVG Volume (30 Days)
- CFFN 678.0K
- RZLT 1.5M
- Earning Date
- CFFN 10-29-2025
- RZLT 11-06-2025
- Dividend Yield
- CFFN 5.41%
- RZLT N/A
- EPS Growth
- CFFN N/A
- RZLT N/A
- EPS
- CFFN 0.47
- RZLT N/A
- Revenue
- CFFN $192,483,000.00
- RZLT N/A
- Revenue This Year
- CFFN $10.56
- RZLT N/A
- Revenue Next Year
- CFFN $11.73
- RZLT N/A
- P/E Ratio
- CFFN $13.36
- RZLT N/A
- Revenue Growth
- CFFN N/A
- RZLT N/A
- 52 Week Low
- CFFN $4.90
- RZLT $2.22
- 52 Week High
- CFFN $7.20
- RZLT $9.72
- Technical
- Relative Strength Index (RSI)
- CFFN 45.92
- RZLT 67.17
- Support Level
- CFFN $6.21
- RZLT $8.97
- Resistance Level
- CFFN $6.46
- RZLT $9.72
- Average True Range (ATR)
- CFFN 0.12
- RZLT 0.60
- MACD
- CFFN -0.03
- RZLT 0.03
- Stochastic Oscillator
- CFFN 21.21
- RZLT 74.71
About CFFN Capitol Federal Financial Inc.
Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.